Shandong Lukang Pharmaceutical Co Ltd (600789) — Cash Flow Reinvestment Rate
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Cash Flow Reinvestment Rate of 0.44x as of June 2025, reinvesting CN¥126.25 Million (capex CN¥88.93 Million plus investments CN¥-37.33 Million) from operating cash flow of CN¥285.47 Million. Explore Shandong Lukang Pharmaceutical Co Ltd (600789) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Lukang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Shandong Lukang Pharmaceutical Co Ltd across 28 annual periods. Also explore 600789 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Shandong Lukang Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600789 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥340.05 Million | CN¥698.17 Million | CN¥338.86 Million | ▼ -63.5% |
| 2024 | 1.34x | CN¥538.05 Million | CN¥402.82 Million | CN¥279.18 Million | ▲ +14.0% |
| 2023 | 1.17x | CN¥707.69 Million | CN¥604.01 Million | CN¥337.91 Million | ▲ +17.2% |
| 2022 | 1.00x | CN¥444.18 Million | CN¥444.38 Million | CN¥428.36 Million | ▼ -71.8% |
| 2021 | 3.54x | CN¥528.93 Million | CN¥149.33 Million | CN¥486.75 Million | ▲ +11.0% |
| 2020 | 3.19x | CN¥748.51 Million | CN¥234.55 Million | CN¥703.12 Million | ▲ +6.1% |
| 2019 | 3.01x | CN¥1.09 Billion | CN¥361.87 Million | CN¥828.61 Million | ▼ -10.7% |
| 2018 | 3.37x | CN¥1.18 Billion | CN¥351.09 Million | CN¥855.24 Million | ▼ -16.3% |
| 2017 | 4.02x | CN¥1.11 Billion | CN¥275.51 Million | CN¥780.71 Million | ▲ +70.4% |
| 2016 | 2.36x | CN¥699.51 Million | CN¥296.23 Million | CN¥371.51 Million | ▼ -71.6% |
| 2015 | 8.31x | CN¥651.58 Million | CN¥78.39 Million | CN¥164.54 Million | ▲ +665.1% |
| 2014 | 1.09x | CN¥117.94 Million | CN¥108.56 Million | CN¥117.94 Million | ▲ +21.0% |
| 2013 | 0.90x | CN¥230.35 Million | CN¥256.50 Million | CN¥230.35 Million | ▼ -63.6% |
| 2012 | 2.47x | CN¥284.40 Million | CN¥115.20 Million | CN¥284.40 Million | ▼ -29.0% |
| 2011 | 3.48x | CN¥428.82 Million | CN¥123.28 Million | CN¥428.82 Million | ▲ +269.6% |
| 2010 | 0.94x | CN¥290.69 Million | CN¥308.88 Million | CN¥290.69 Million | ▲ +169.9% |
| 2009 | 0.35x | CN¥69.57 Million | CN¥199.49 Million | CN¥69.57 Million | ▼ -4.7% |
| 2008 | 0.37x | CN¥76.58 Million | CN¥209.39 Million | CN¥76.58 Million | ▲ +116.0% |
| 2007 | 0.17x | CN¥23.25 Million | CN¥137.30 Million | CN¥23.25 Million | ▼ -56.9% |
| 2006 | 0.39x | CN¥22.12 Million | CN¥56.24 Million | CN¥22.12 Million | ▲ +3.7% |
| 2005 | 0.38x | CN¥61.27 Million | CN¥161.64 Million | CN¥61.27 Million | ▼ -82.0% |
| 2004 | 2.10x | CN¥133.10 Million | CN¥63.24 Million | CN¥133.10 Million | ▲ +96.6% |
| 2003 | 1.07x | CN¥179.25 Million | CN¥167.42 Million | CN¥179.25 Million | ▲ +69.0% |
| 2002 | 0.63x | CN¥199.94 Million | CN¥315.59 Million | CN¥199.94 Million | ▼ -15.8% |
| 2001 | 0.75x | CN¥203.50 Million | CN¥270.43 Million | CN¥203.50 Million | ▼ -93.3% |
| 2000 | 11.21x | CN¥250.64 Million | CN¥22.36 Million | CN¥250.64 Million | ▲ +312.0% |
| 1999 | 2.72x | CN¥95.56 Million | CN¥35.12 Million | CN¥95.56 Million | ▼ -20.0% |
| 1998 | 3.40x | CN¥156.96 Million | CN¥46.18 Million | CN¥156.96 Million | — |